QUALITY IMPROVEMENT PROGRAM [QIP]
The Government of India launched the quality improvement program in 1970. One of the many objectives of the program is to upgrade the expertise and capabilities of the faculty members of the degree level institutions in the country. In QIP, only sponsored teachers are eligible for admission to both Master’s and Doctoral degree programs, with an aim to enable teachers to acquire Master’s / Doctoral degrees and imbibe in them a culture of research and better teaching educational capabilities by exposing them to the environment of the institutes of study
There are three main activities under QIP serving the faculty of degree level institutions:
- Providing opportunities to faculty members to improve their qualification by offering admissions to Master’s and PhD degree programs
- Organizing short term courses for serving teachers
- Curriculum development [CD] cell activities which help to improve classroom teaching and learning
沙巴体育 College of Pharmaceutical Sciences is one such QIP nodal cell, among ten pharmacy institutes across the country which started in 2005. A total of six faculty members from various parts of the country have successfully completed their MPharm through QIP. Similarly, with this scheme, twelve of them received their PhD degrees.
QIP coordinator details: Professor C Mallikarjuna Rao, Principal, MCOPS, 沙巴体育 Academy of Higher Education, 沙巴体育- 576104, Tel: 0820 2922482, fax: 0820 2571998, email: mallik.rao@manipal.edu; office.mcops@manipal.edu
Short term QIP programs conducted at 沙巴体育 College of Pharmaceutical Sciences
S No |
?Subject |
Date |
1 |
Clinical 沙巴体育 & Regulatory Affairs- An Update |
19th Sept - 1st Oct 2005 |
2 |
Emerging Areas in Drug Discovery & Development |
7th - 19th November 2005 |
3 |
Frontiers in Pharmaceutical Sciences |
30th - 11th February 2006 |
4 |
Challenges & Opportunities in Pharmaceutical 沙巴体育 |
12th - 24th November 2007 |
5 |
Search & 沙巴体育 – Gateway to Pharma Knowledge |
4th - 16th August 2008 |
6 |
Opportunities & Challenges in Clinical 沙巴体育 & Management for Better Patient Care |
18th - 30th August 2008 |
7 |
Recent Advances in the Synthesis of Heterocyclic Compounds & Advances in Instrumental Methods of Analysis |
20th Oct - 1st Nov 2008 |
8 |
Nanotechnology & Nanomedicine for Improved Drug Delivery & Better Health Care Management |
3rd - 15th November 2008 |
9 |
Patient Care Through Pharmaceutical Prospecting and Marketing |
2nd - 14th February 2009 |
10 |
1st - 14th June 2010 |
|
11 |
Challenges in Translational 沙巴体育 |
1st - 14th June 2011 |
12 |
28th - 8th June 2012 |
|
13 |
9th - 23rd June 2012 |
|
14 |
An insight into Bio-pharmaceuticals- Technologies, Analysis and Regulatory Issues |
25th June - 7th July 2012 |
15 |
Leads from natural and synthetic sources |
3rd - 15th June 2013 |
16 |
Biosimilars- Technologies and Prospects |
17th - 29th June 2013 |
17 |
1st -13th July 2013 |
|
18 |
16th - 28th June 2014 |
|
19 |
Frontiers in Pharmacology of Drug research & Recent trends in Pharmacy Practice | 5th - 17th January 2015 |
20 | New chemical entities and Biosimilars: Strategies for design and development | 18th - 31st January 2016 |
21 | Recent trends in Drug-Product Development, Phytopharmaceuticals and Analytical Techniques | 15-27 Feb 2016 ? |
22 | Formulation and management of quality medicines | 12th - 24th September 2016 |
23 | Emerging Insights & Approaches in Pharmacological and Phytochemical 沙巴体育 | 28 Jan – 10 Feb, 2017 ? |
24 | Emerging Trends in Health Care: Bench to Bed side | 6-18 March, 2017 ? |
24 | Manufacturing, Marketing,?Management and Regulations of Drugs & Biological Products | 11-23 Sept, 2017 ? |
25 | Challenges and Strategies for drug design and formulation development | 13-25 Nov, 2017 ? |
26 | Translational 沙巴体育 in Modern and Indigenous Medicine | 5-17 March, 2018 |